{"donor_id":"TARGET-10-PALZRZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"17","donor_age_at_last_followup":"22","donor_relapse_interval":"1768","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1991","donor_interval_of_last_followup":"1991","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALZVV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":"17","donor_relapse_interval":"447","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"590","donor_interval_of_last_followup":"590","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PALZZG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"7","donor_age_at_last_followup":"10","donor_relapse_interval":"902","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"982","donor_interval_of_last_followup":"982","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMABV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"6","donor_age_at_enrollment":"6","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMANN","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMAYA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":"477","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBCT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBDA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBFS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":"1362","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBNA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":"1403","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBRP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBWL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"3","donor_age_at_last_followup":null,"donor_relapse_interval":"1143","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMBWU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCEZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"3","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCGY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCHE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCKJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"20","donor_age_at_enrollment":"20","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCLG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"2","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCMC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":"19","donor_relapse_interval":"893","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1150","donor_interval_of_last_followup":"1150","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCMK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"2","donor_age_at_enrollment":"1","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCPC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCPG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCRI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"11","donor_age_at_enrollment":"11","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMCTK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":"463","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMDJV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMDKS","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":"13","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"69","donor_interval_of_last_followup":"69","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMDRM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"7","donor_age_at_last_followup":"10","donor_relapse_interval":"994","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1213","donor_interval_of_last_followup":"1213","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMDVB","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMDXD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"13","donor_age_at_enrollment":"13","donor_age_at_last_followup":"13","donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"210","donor_interval_of_last_followup":"210","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEEF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEEG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEEK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"14","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEEV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"18","donor_age_at_enrollment":"18","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEIM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"13","donor_age_at_last_followup":null,"donor_relapse_interval":"1191","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMESL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"16","donor_age_at_enrollment":"16","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMETS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"17","donor_age_at_enrollment":"17","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEUU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"19","donor_age_at_enrollment":"19","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMEYI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"15","donor_age_at_last_followup":null,"donor_relapse_interval":"1574","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAMFFL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":"15","donor_age_at_enrollment":"14","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANBXW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2872","donor_age_at_last_followup":null,"donor_relapse_interval":"1764","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANCVR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2329","donor_age_at_last_followup":"8","donor_relapse_interval":"285","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"473","donor_interval_of_last_followup":"473","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANDCF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2683","donor_age_at_last_followup":"10","donor_relapse_interval":"908","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1069","donor_interval_of_last_followup":"1069","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANDPX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1393","donor_age_at_last_followup":null,"donor_relapse_interval":"1961","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANDRS","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6673","donor_age_at_last_followup":"21","donor_relapse_interval":"978","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1063","donor_interval_of_last_followup":"1063","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANDWE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5213","donor_age_at_last_followup":"19","donor_relapse_interval":"1137","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1571","donor_interval_of_last_followup":"1571","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANDYD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"5953","donor_age_at_last_followup":"17","donor_relapse_interval":"209","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"345","donor_interval_of_last_followup":"345","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANGIF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4087","donor_age_at_last_followup":"12","donor_relapse_interval":"368","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"428","donor_interval_of_last_followup":"428","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANIEU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2823","donor_age_at_last_followup":"9","donor_relapse_interval":"220","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"526","donor_interval_of_last_followup":"526","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANJWJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4018","donor_age_at_last_followup":null,"donor_relapse_interval":"689","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANKAK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2342","donor_age_at_last_followup":"9","donor_relapse_interval":"950","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1095","donor_interval_of_last_followup":"1095","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANKKU","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"454","donor_age_at_last_followup":"3","donor_relapse_interval":"546","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"563","donor_interval_of_last_followup":"563","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANPJW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4579","donor_age_at_last_followup":null,"donor_relapse_interval":"424","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANRVB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4577","donor_age_at_last_followup":"19","donor_relapse_interval":"1442","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2188","donor_interval_of_last_followup":"2188","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANRYX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"26","donor_age_at_enrollment":"9556","donor_age_at_last_followup":"28","donor_relapse_interval":"404","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"603","donor_interval_of_last_followup":"603","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANSBR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"21","donor_age_at_enrollment":"7519","donor_age_at_last_followup":"25","donor_relapse_interval":"728","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1688","donor_interval_of_last_followup":"1688","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANSDA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4616","donor_age_at_last_followup":"16","donor_relapse_interval":"863","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1141","donor_interval_of_last_followup":"1141","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANSHK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"837","donor_age_at_last_followup":null,"donor_relapse_interval":"1354","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANSPW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4798","donor_age_at_last_followup":"16","donor_relapse_interval":"113","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"870","donor_interval_of_last_followup":"870","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANSUL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"886","donor_age_at_last_followup":"5","donor_relapse_interval":"929","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1068","donor_interval_of_last_followup":"1068","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANTSM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2591","donor_age_at_last_followup":"10","donor_relapse_interval":"1087","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1214","donor_interval_of_last_followup":"1214","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANUHA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1302","donor_age_at_last_followup":null,"donor_relapse_interval":"1294","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANUKN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"5957","donor_age_at_last_followup":null,"donor_relapse_interval":"1028","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANUSN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1043","donor_age_at_last_followup":"8","donor_relapse_interval":"1517","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1715","donor_interval_of_last_followup":"1715","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANVIC","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2766","donor_age_at_last_followup":"12","donor_relapse_interval":"969","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1752","donor_interval_of_last_followup":"1752","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANVJN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"899","donor_age_at_last_followup":null,"donor_relapse_interval":"1713","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANVYR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6140","donor_age_at_last_followup":"18","donor_relapse_interval":"288","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"517","donor_interval_of_last_followup":"517","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANWHJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1131","donor_age_at_last_followup":null,"donor_relapse_interval":"1446","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANWYH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"1786","donor_age_at_last_followup":"9","donor_relapse_interval":"1361","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1418","donor_interval_of_last_followup":"1418","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANXGD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"3011","donor_age_at_last_followup":"10","donor_relapse_interval":"731","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"775","donor_interval_of_last_followup":"775","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANXPE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1358","donor_age_at_last_followup":null,"donor_relapse_interval":"1217","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANXXY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2703","donor_age_at_last_followup":"11","donor_relapse_interval":"788","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1450","donor_interval_of_last_followup":"1450","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANYGB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2788","donor_age_at_last_followup":"13","donor_relapse_interval":"1321","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2110","donor_interval_of_last_followup":"2110","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANYYV","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1224","donor_age_at_last_followup":null,"donor_relapse_interval":"1304","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANYZE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1479","donor_age_at_last_followup":null,"donor_relapse_interval":"1272","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANZAM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6244","donor_age_at_last_followup":"21","donor_relapse_interval":"574","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1286","donor_interval_of_last_followup":"1286","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANZEV","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1468","donor_age_at_last_followup":"8","donor_relapse_interval":"661","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1517","donor_interval_of_last_followup":"1517","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANZPJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4756","donor_age_at_last_followup":"16","donor_relapse_interval":"932","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"953","donor_interval_of_last_followup":"953","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANZWG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1237","donor_age_at_last_followup":"5","donor_relapse_interval":"293","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"475","donor_interval_of_last_followup":"475","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PANZXC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"739","donor_age_at_last_followup":"6","donor_relapse_interval":"1115","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1412","donor_interval_of_last_followup":"1412","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPACP","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2013","donor_age_at_last_followup":null,"donor_relapse_interval":"1303","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPAGK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"853","donor_age_at_last_followup":null,"donor_relapse_interval":"771","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPAIZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2356","donor_age_at_last_followup":null,"donor_relapse_interval":"932","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPBSY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"883","donor_age_at_last_followup":"4","donor_relapse_interval":"77","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"665","donor_interval_of_last_followup":"665","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPCJS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"663","donor_age_at_last_followup":null,"donor_relapse_interval":"612","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPCPC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"979","donor_age_at_last_followup":null,"donor_relapse_interval":"1017","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPCUR","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1098","donor_age_at_last_followup":"4","donor_relapse_interval":"222","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"369","donor_interval_of_last_followup":"369","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPCVA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5040","donor_age_at_last_followup":"18","donor_relapse_interval":"1302","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1469","donor_interval_of_last_followup":"1469","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPCVZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"1833","donor_age_at_last_followup":null,"donor_relapse_interval":"1255","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPDEE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"10","donor_age_at_enrollment":"3798","donor_age_at_last_followup":"13","donor_relapse_interval":"995","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1115","donor_interval_of_last_followup":"1115","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPDJM","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"829","donor_age_at_last_followup":null,"donor_relapse_interval":"722","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPDKJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1449","donor_age_at_last_followup":"8","donor_relapse_interval":"819","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1456","donor_interval_of_last_followup":"1456","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPDUF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1217","donor_age_at_last_followup":null,"donor_relapse_interval":"1191","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPDUV","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"1986","donor_age_at_last_followup":null,"donor_relapse_interval":"1524","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPDWT","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2146","donor_age_at_last_followup":null,"donor_relapse_interval":"868","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPEAB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1355","donor_age_at_last_followup":null,"donor_relapse_interval":"1340","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPECF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"785","donor_age_at_last_followup":null,"donor_relapse_interval":"1178","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPEFH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2543","donor_age_at_last_followup":"9","donor_relapse_interval":"816","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"852","donor_interval_of_last_followup":"852","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPEGV","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"3872","donor_age_at_last_followup":"13","donor_relapse_interval":"787","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"923","donor_interval_of_last_followup":"923","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPEJN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1129","donor_age_at_last_followup":"6","donor_relapse_interval":"342","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"934","donor_interval_of_last_followup":"934","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPELE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"10","donor_age_at_enrollment":"3749","donor_age_at_last_followup":"15","donor_relapse_interval":"1244","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1550","donor_interval_of_last_followup":"1550","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPERG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6740","donor_age_at_last_followup":null,"donor_relapse_interval":"763","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPESW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1054","donor_age_at_last_followup":null,"donor_relapse_interval":"1120","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPFDT","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1095","donor_age_at_last_followup":null,"donor_relapse_interval":"873","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPFWH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6103","donor_age_at_last_followup":"19","donor_relapse_interval":"711","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"819","donor_interval_of_last_followup":"819","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPGFP","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"10","donor_age_at_enrollment":"3519","donor_age_at_last_followup":"12","donor_relapse_interval":"859","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"945","donor_interval_of_last_followup":"945","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPGYC","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1335","donor_age_at_last_followup":"9","donor_relapse_interval":"1186","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"2003","donor_interval_of_last_followup":"2003","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPHCJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6210","donor_age_at_last_followup":null,"donor_relapse_interval":"523","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPHEK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"3187","donor_age_at_last_followup":"11","donor_relapse_interval":"445","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"647","donor_interval_of_last_followup":"647","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPHJF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2511","donor_age_at_last_followup":"8","donor_relapse_interval":"282","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"483","donor_interval_of_last_followup":"483","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPHMH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"30","donor_age_at_enrollment":"10946","donor_age_at_last_followup":"31","donor_relapse_interval":"322","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"397","donor_interval_of_last_followup":"397","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPHXN","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"5998","donor_age_at_last_followup":"18","donor_relapse_interval":"499","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"724","donor_interval_of_last_followup":"724","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPIDY","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"918","donor_age_at_last_followup":null,"donor_relapse_interval":"986","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPIJB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"2005","donor_age_at_last_followup":null,"donor_relapse_interval":"588","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPIPW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"3417","donor_age_at_last_followup":"13","donor_relapse_interval":"1438","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1459","donor_interval_of_last_followup":"1459","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPIRZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4892","donor_age_at_last_followup":"16","donor_relapse_interval":"685","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1008","donor_interval_of_last_followup":"1008","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPISG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5203","donor_age_at_last_followup":null,"donor_relapse_interval":"1013","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPJHB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"2005","donor_age_at_last_followup":null,"donor_relapse_interval":"1260","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPJHR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4016","donor_age_at_last_followup":"14","donor_relapse_interval":"1129","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1186","donor_interval_of_last_followup":"1186","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPJIB","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"903","donor_age_at_last_followup":"6","donor_relapse_interval":"851","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1344","donor_interval_of_last_followup":"1344","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPJPH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"5620","donor_age_at_last_followup":"16","donor_relapse_interval":"331","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"378","donor_interval_of_last_followup":"378","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPJXI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"3250","donor_age_at_last_followup":null,"donor_relapse_interval":"1409","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPKGY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"5856","donor_age_at_last_followup":"20","donor_relapse_interval":"1222","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1500","donor_interval_of_last_followup":"1500","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPKNC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6599","donor_age_at_last_followup":"22","donor_relapse_interval":"980","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1413","donor_interval_of_last_followup":"1413","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPLDL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2677","donor_age_at_last_followup":"11","donor_relapse_interval":"544","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1187","donor_interval_of_last_followup":"1187","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPLDM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1124","donor_age_at_last_followup":null,"donor_relapse_interval":"1212","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPLTZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2030","donor_age_at_last_followup":null,"donor_relapse_interval":"1321","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPLUG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"506","donor_age_at_last_followup":"5","donor_relapse_interval":"784","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1155","donor_interval_of_last_followup":"1155","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPMFI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"1711","donor_age_at_last_followup":null,"donor_relapse_interval":"1343","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPMVB","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"699","donor_age_at_last_followup":"6","donor_relapse_interval":"776","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1413","donor_interval_of_last_followup":"1413","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPMYD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5103","donor_age_at_last_followup":"16","donor_relapse_interval":"496","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"692","donor_interval_of_last_followup":"692","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPNFY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4151","donor_age_at_last_followup":null,"donor_relapse_interval":"1083","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPNMY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5109","donor_age_at_last_followup":null,"donor_relapse_interval":"881","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPNNX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"5486","donor_age_at_last_followup":"17","donor_relapse_interval":"686","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"846","donor_interval_of_last_followup":"846","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPNTA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1563","donor_age_at_last_followup":"8","donor_relapse_interval":"583","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1405","donor_interval_of_last_followup":"1405","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPNZE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"5435","donor_age_at_last_followup":null,"donor_relapse_interval":"1044","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPPGN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"396","donor_age_at_last_followup":null,"donor_relapse_interval":"387","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPPHL","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2695","donor_age_at_last_followup":null,"donor_relapse_interval":"1332","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPRCS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5147","donor_age_at_last_followup":"15","donor_relapse_interval":"353","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"460","donor_interval_of_last_followup":"460","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPRFE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"940","donor_age_at_last_followup":"4","donor_relapse_interval":"190","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"391","donor_interval_of_last_followup":"391","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPRYB","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2334","donor_age_at_last_followup":"8","donor_relapse_interval":"475","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"647","donor_interval_of_last_followup":"647","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPSPG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4782","donor_age_at_last_followup":"17","donor_relapse_interval":"965","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1533","donor_interval_of_last_followup":"1533","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPSPN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4173","donor_age_at_last_followup":"13","donor_relapse_interval":"514","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"733","donor_interval_of_last_followup":"733","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPTGG","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1610","donor_age_at_last_followup":null,"donor_relapse_interval":"664","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPTHJ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1221","donor_age_at_last_followup":null,"donor_relapse_interval":"1012","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPTLM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"679","donor_age_at_last_followup":"4","donor_relapse_interval":"531","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"919","donor_interval_of_last_followup":"919","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPUDR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1305","donor_age_at_last_followup":null,"donor_relapse_interval":"889","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPVNW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"388","donor_age_at_last_followup":null,"donor_relapse_interval":"456","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPVTA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1020","donor_age_at_last_followup":null,"donor_relapse_interval":"1012","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPXED","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6057","donor_age_at_last_followup":"20","donor_relapse_interval":"1088","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1185","donor_interval_of_last_followup":"1185","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPYEX","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4860","donor_age_at_last_followup":"16","donor_relapse_interval":"888","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1146","donor_interval_of_last_followup":"1146","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPZGR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"4993","donor_age_at_last_followup":"16","donor_relapse_interval":"404","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"859","donor_interval_of_last_followup":"859","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPZNK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"10","donor_age_at_enrollment":"3658","donor_age_at_last_followup":"12","donor_relapse_interval":"625","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"883","donor_interval_of_last_followup":"883","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PAPZST","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"5491","donor_age_at_last_followup":null,"donor_relapse_interval":"171","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARACA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"972","donor_age_at_last_followup":"5","donor_relapse_interval":"126","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"806","donor_interval_of_last_followup":"806","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARAKF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"3051","donor_age_at_last_followup":null,"donor_relapse_interval":"1088","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARARJ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1129","donor_age_at_last_followup":"4","donor_relapse_interval":"397","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"455","donor_interval_of_last_followup":"455","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARBDN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2071","donor_age_at_last_followup":"9","donor_relapse_interval":"919","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1096","donor_interval_of_last_followup":"1096","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARBRK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2636","donor_age_at_last_followup":"10","donor_relapse_interval":"778","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1124","donor_interval_of_last_followup":"1124","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARBVI","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"4948","donor_age_at_last_followup":"17","donor_relapse_interval":"958","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1172","donor_interval_of_last_followup":"1172","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARCBK","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6030","donor_age_at_last_followup":"18","donor_relapse_interval":"580","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"628","donor_interval_of_last_followup":"628","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARCHB","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"787","donor_age_at_last_followup":null,"donor_relapse_interval":"801","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARDLR","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"3042","donor_age_at_last_followup":null,"donor_relapse_interval":"409","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARDNF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"3916","donor_age_at_last_followup":"11","donor_relapse_interval":"136","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"212","donor_interval_of_last_followup":"212","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARDWE","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6685","donor_age_at_last_followup":"20","donor_relapse_interval":"369","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"504","donor_interval_of_last_followup":"504","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARFLV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"5906","donor_age_at_last_followup":"17","donor_relapse_interval":"293","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"334","donor_interval_of_last_followup":"334","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARFTR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2127","donor_age_at_last_followup":"7","donor_relapse_interval":"284","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"465","donor_interval_of_last_followup":"465","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARFVZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"3034","donor_age_at_last_followup":null,"donor_relapse_interval":"952","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARGFV","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1033","donor_age_at_last_followup":null,"donor_relapse_interval":"970","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARGHW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"19","donor_age_at_enrollment":"6842","donor_age_at_last_followup":null,"donor_relapse_interval":"482","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARGML","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"789","donor_age_at_last_followup":"3","donor_relapse_interval":"116","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"187","donor_interval_of_last_followup":"187","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARGVZ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"10","donor_age_at_enrollment":"3571","donor_age_at_last_followup":null,"donor_relapse_interval":"989","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARHUM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"19","donor_age_at_enrollment":"6907","donor_age_at_last_followup":"22","donor_relapse_interval":"876","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1164","donor_interval_of_last_followup":"1164","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARIAD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"596","donor_age_at_last_followup":"3","donor_relapse_interval":"339","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"510","donor_interval_of_last_followup":"510","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARJSR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4093","donor_age_at_last_followup":"14","donor_relapse_interval":"588","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"853","donor_interval_of_last_followup":"853","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARJZZ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1538","donor_age_at_last_followup":"7","donor_relapse_interval":"795","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"993","donor_interval_of_last_followup":"993","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARKNJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"732","donor_age_at_last_followup":"3","donor_relapse_interval":"440","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"464","donor_interval_of_last_followup":"464","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARLAF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1449","donor_age_at_last_followup":null,"donor_relapse_interval":"618","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARLEK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"3215","donor_age_at_last_followup":null,"donor_relapse_interval":"799","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARLZG","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4093","donor_age_at_last_followup":null,"donor_relapse_interval":"1003","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARMSP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6555","donor_age_at_last_followup":"20","donor_relapse_interval":"441","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"584","donor_interval_of_last_followup":"584","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARMXF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1464","donor_age_at_last_followup":"7","donor_relapse_interval":"640","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"951","donor_interval_of_last_followup":"951","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARNDR","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6243","donor_age_at_last_followup":"18","donor_relapse_interval":"202","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"439","donor_interval_of_last_followup":"439","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARNMF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1024","donor_age_at_last_followup":null,"donor_relapse_interval":"1022","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARNSH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6419","donor_age_at_last_followup":null,"donor_relapse_interval":"1022","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARNTW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1111","donor_age_at_last_followup":null,"donor_relapse_interval":"957","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPCA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2176","donor_age_at_last_followup":"7","donor_relapse_interval":"251","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"477","donor_interval_of_last_followup":"477","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPNM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"4941","donor_age_at_last_followup":"14","donor_relapse_interval":"116","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"233","donor_interval_of_last_followup":"233","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPRD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"3889","donor_age_at_last_followup":"13","donor_relapse_interval":"743","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"944","donor_interval_of_last_followup":"944","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPRW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"5479","donor_age_at_last_followup":"16","donor_relapse_interval":"377","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"442","donor_interval_of_last_followup":"442","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPVU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"1","donor_age_at_enrollment":"537","donor_age_at_last_followup":null,"donor_relapse_interval":"484","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPYS","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"15","donor_age_at_enrollment":"5372","donor_age_at_last_followup":"16","donor_relapse_interval":"371","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"472","donor_interval_of_last_followup":"472","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARPZJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"648","donor_age_at_last_followup":null,"donor_relapse_interval":"419","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARRKW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2505","donor_age_at_last_followup":"10","donor_relapse_interval":"705","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1053","donor_interval_of_last_followup":"1053","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARSGC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1133","donor_age_at_last_followup":null,"donor_relapse_interval":"932","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARSRH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"10","donor_age_at_enrollment":"3532","donor_age_at_last_followup":"11","donor_relapse_interval":"297","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"500","donor_interval_of_last_followup":"500","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARSZH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4719","donor_age_at_last_followup":null,"donor_relapse_interval":"1001","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARTJL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1060","donor_age_at_last_followup":null,"donor_relapse_interval":"509","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARTKL","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1089","donor_age_at_last_followup":"5","donor_relapse_interval":"805","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"900","donor_interval_of_last_followup":"900","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARTRW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"6","donor_age_at_enrollment":"2062","donor_age_at_last_followup":null,"donor_relapse_interval":"675","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARTXF","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1090","donor_age_at_last_followup":"6","donor_relapse_interval":"686","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"1001","donor_interval_of_last_followup":"1001","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARTYT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"847","donor_age_at_last_followup":null,"donor_relapse_interval":"257","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARUBK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"13","donor_age_at_enrollment":"4601","donor_age_at_last_followup":"14","donor_relapse_interval":"399","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"560","donor_interval_of_last_followup":"560","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARUGP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"759","donor_age_at_last_followup":"3","donor_relapse_interval":"223","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"289","donor_interval_of_last_followup":"289","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARUIW","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"1777","donor_age_at_last_followup":null,"donor_relapse_interval":"945","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARVHA","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6228","donor_age_at_last_followup":"18","donor_relapse_interval":"380","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"520","donor_interval_of_last_followup":"520","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARVWD","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"17","donor_age_at_enrollment":"6375","donor_age_at_last_followup":"18","donor_relapse_interval":"252","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"255","donor_interval_of_last_followup":"255","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARWVN","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"845","donor_age_at_last_followup":null,"donor_relapse_interval":"1040","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PARXMC","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2526","donor_age_at_last_followup":null,"donor_relapse_interval":"672","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASCIU","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"795","donor_age_at_last_followup":"5","donor_relapse_interval":"735","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"977","donor_interval_of_last_followup":"977","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASDYK","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1310","donor_age_at_last_followup":"6","donor_relapse_interval":"520","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"736","donor_interval_of_last_followup":"736","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASEVJ","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"11","donor_age_at_enrollment":"4086","donor_age_at_last_followup":"14","donor_relapse_interval":"678","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"892","donor_interval_of_last_followup":"892","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASFPU","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5208","donor_age_at_last_followup":"15","donor_relapse_interval":"186","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"410","donor_interval_of_last_followup":"410","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASFXA","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2374","donor_age_at_last_followup":"8","donor_relapse_interval":"455","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"645","donor_interval_of_last_followup":"645","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASHUI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"5","donor_age_at_enrollment":"1865","donor_age_at_last_followup":"7","donor_relapse_interval":"574","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"605","donor_interval_of_last_followup":"605","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASKAY","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"2","donor_age_at_enrollment":"585","donor_age_at_last_followup":"3","donor_relapse_interval":"312","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"487","donor_interval_of_last_followup":"487","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASKHT","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"12","donor_age_at_enrollment":"4562","donor_age_at_last_followup":"14","donor_relapse_interval":"550","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"716","donor_interval_of_last_followup":"716","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASLZM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2496","donor_age_at_last_followup":"8","donor_relapse_interval":"258","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"407","donor_interval_of_last_followup":"407","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASMVF","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"1163","donor_age_at_last_followup":null,"donor_relapse_interval":"671","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASRXC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"3","donor_age_at_enrollment":"919","donor_age_at_last_followup":null,"donor_relapse_interval":"650","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASSUP","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2856","donor_age_at_last_followup":"10","donor_relapse_interval":"669","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"798","donor_interval_of_last_followup":"798","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASSXJ","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"4","donor_age_at_enrollment":"1329","donor_age_at_last_followup":"5","donor_relapse_interval":"323","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"552","donor_interval_of_last_followup":"552","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASUBW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5098","donor_age_at_last_followup":"15","donor_relapse_interval":"336","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"474","donor_interval_of_last_followup":"474","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASVUW","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2953","donor_age_at_last_followup":"9","donor_relapse_interval":"310","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"420","donor_interval_of_last_followup":"420","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASYGM","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"8","donor_age_at_enrollment":"2750","donor_age_at_last_followup":"9","donor_relapse_interval":"314","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"429","donor_interval_of_last_followup":"429","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PASYRH","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"16","donor_age_at_enrollment":"5836","donor_age_at_last_followup":"18","donor_relapse_interval":"453","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"576","donor_interval_of_last_followup":"576","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PATCTI","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"7","donor_age_at_enrollment":"2414","donor_age_at_last_followup":"8","donor_relapse_interval":"363","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"482","donor_interval_of_last_followup":"482","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PATEEN","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"23","donor_age_at_enrollment":"8568","donor_age_at_last_followup":"25","donor_relapse_interval":"418","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"516","donor_interval_of_last_followup":"516","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PATISC","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"9","donor_age_at_enrollment":"3131","donor_age_at_last_followup":"10","donor_relapse_interval":"302","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"408","donor_interval_of_last_followup":"408","donor_notes":null,"_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PATSAH","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"18","donor_age_at_enrollment":"6424","donor_age_at_last_followup":null,"donor_relapse_interval":"138","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"Survival time set to unknown for still living donors.","_project_id":"ALL-US"}
{"donor_id":"TARGET-10-PATTEE","donor_sex":"female","donor_region_of_residence":null,"donor_vital_status":"deceased","disease_status_last_followup":"relapse","donor_relapse_type":"progression (liquid tumours)","donor_age_at_diagnosis":"14","donor_age_at_enrollment":"5021","donor_age_at_last_followup":"14","donor_relapse_interval":"98","donor_diagnosis_icd10":"C91.0","donor_tumour_staging_system_at_diagnosis":null,"donor_tumour_stage_at_diagnosis":null,"donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":"232","donor_interval_of_last_followup":"232","donor_notes":null,"_project_id":"ALL-US"}
